BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mallio CA, Rovira À, Parizel PM, Quattrocchi CC. Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies. Neuroradiology 2020;62:925-34. [DOI: 10.1007/s00234-020-02434-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Rovira À, Auger C. Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity. AJR Am J Roentgenol 2021. [PMID: 34786958 DOI: 10.2214/AJR.21.27069] [Reference Citation Analysis]
2 Kartamihardja AAP, Ariyani W, Hanaoka H, Taketomi-Takahashi A, Koibuchi N, Tsushima Y. The Role of Ferrous Ion in the Effect of the Gadolinium-Based Contrast Agents (GBCA) on the Purkinje Cells Arborization: An In Vitro Study. Diagnostics (Basel) 2021;11:2310. [PMID: 34943547 DOI: 10.3390/diagnostics11122310] [Reference Citation Analysis]
3 Halvorsen M, Edeklev CS, Fraser-Green J, Løvland G, Vatnehol SAS, Gjertsen Ø, Nedregaard B, Sletteberg R, Ringstad G, Eide PK. Off-label intrathecal use of gadobutrol: safety study and comparison of administration protocols. Neuroradiology 2021;63:51-61. [PMID: 32803338 DOI: 10.1007/s00234-020-02519-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Baykara M, Ozcan M, Bilgen M, Kelestimur H. Interference of gadolinium dechelated from MR contrast agents by calcium signaling in neuronal cells of GnRH. J Cell Physiol 2021;236:2139-43. [PMID: 32740939 DOI: 10.1002/jcp.30000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mallio CA, Messina L, Parillo M, Lo Vullo G, Beomonte Zobel B, Parizel PM, Quattrocchi CC. Anterior pituitary gland T1 signal intensity is influenced by time delay after injection of gadodiamide. Sci Rep 2020;10:14967. [PMID: 32917963 DOI: 10.1038/s41598-020-71981-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Liachenko SM, Sadovova NV, Tripp A, Ghorai S, Patri AK, Hanig JP, Cohen JE, Krefting I. Optimization of Detection of Gadodiamide Brain Retention in Rats Using Quantitative T2 Mapping and Intraperitoneal Administration. J Magn Reson Imaging 2022. [PMID: 35278003 DOI: 10.1002/jmri.28149] [Reference Citation Analysis]
7 Hamamoto K, Chiba E, Oyama-Manabe N, Yuzawa H, Shinmoto H. Assessment of pulmonary arteriovenous malformation with ultra-short echo time magnetic resonance imaging. Eur J Radiol 2022;147:110144. [PMID: 34999474 DOI: 10.1016/j.ejrad.2021.110144] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mallio CA, Parillo M, Zobel BB, Parizel PM, Quattrocchi CC. Effect of Exposure to Gadodiamide and Brain Irradiation on T 1 ‐Weighted Images and ADC Maps of the Dentate Nucleus. J Magn Reson Imaging 2020;52:1525-30. [DOI: 10.1002/jmri.27198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Leiner T. Is gadolinium-enhanced magnetic resonance imaging possible without leaving a trace? J Magn Reson Imaging 2021;53:1293-4. [PMID: 33559382 DOI: 10.1002/jmri.27535] [Reference Citation Analysis]
10 Li KL, Lewis D, Coope DJ, Roncaroli F, Agushi E, Pathmanaban ON, King AT, Zhao S, Jackson A, Cootes T, Zhu X. The LEGATOS technique: A new tissue-validated dynamic contrast-enhanced MRI method for whole-brain, high-spatial resolution parametric mapping. Magn Reson Med 2021;86:2122-36. [PMID: 33991126 DOI: 10.1002/mrm.28842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Michali-Stolarska M, Tukiendorf A, Zacharzewska-Gondek A, Jacków-Nowicka J, Chrzanowska J, Trybek G, Bladowska J. MRI Protocol for Pituitary Assessment in Children with Growth or Puberty Disorders-Is Gadolinium Contrast Administration Actually Needed? J Clin Med 2021;10:4598. [PMID: 34640616 DOI: 10.3390/jcm10194598] [Reference Citation Analysis]
12 Smits M. Update on neuroimaging in brain tumours. Curr Opin Neurol 2021;34:497-504. [PMID: 33973902 DOI: 10.1097/WCO.0000000000000950] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tortora M, Tranfa M, D'Elia AC, Pontillo G, Petracca M, Bozzao A, Caranci F, Cervo A, Cosottini M, Falini A, Longo M, Manara R, Muto M, Porcu M, Roccatagliata L, Todeschini A, Saba L, Brunetti A, Cocozza S, Elefante A. Walk Your Talk: Real-World Adherence to Guidelines on the Use of MRI in Multiple Sclerosis. Diagnostics (Basel) 2021;11:1310. [PMID: 34441245 DOI: 10.3390/diagnostics11081310] [Reference Citation Analysis]
14 Knobloch G, Lauff MT, Hanke M, Schwenke C, Hamm B, Wagner M. Non-contrast-enhanced MR-angiography (MRA) of lower extremity peripheral arterial disease at 3 tesla: Examination time and diagnostic performance of 2D quiescent-interval single-shot MRA vs. 3D fast spin-Echo MRA. Magn Reson Imaging 2021;76:17-25. [PMID: 33157187 DOI: 10.1016/j.mri.2020.10.016] [Reference Citation Analysis]
15 Kiessling F. Editorial for "Investigation of Effects of Gadolinium-Based Contrast Agents on Uterine Contractility Using Isolated Rat Myometrium". J Magn Reson Imaging 2021. [PMID: 34719832 DOI: 10.1002/jmri.27980] [Reference Citation Analysis]
16 Patel A, Zolyan A, Itrat A. Long-Term Sequela of Intrathecal Gadolinium Extravasation: Symptoms Mimicking Post-concussive Syndrome. Cureus 2021;13:e14084. [PMID: 33907635 DOI: 10.7759/cureus.14084] [Reference Citation Analysis]
17 Ayers-ringler J, Mcdonald JS, Connors MA, Fisher CR, Han S, Jakaitis DR, Scherer B, Tutor G, Wininger KM, Dai D, Choi D, Salisbury JL, Jannetto PJ, Bornhorst JA, Kadirvel R, Kallmes DF, Mcdonald RJ. Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration. Radiology. [DOI: 10.1148/radiol.210559] [Cited by in F6Publishing: 1] [Reference Citation Analysis]